Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month

SCOTTSDALE, AZ, USA, August 21st, 2026, FinanceWire

Promise, a Scottsdale, Arizona-based telehealth platform for peptide therapy, weight management, and hormone care, today announced the release of a new analysis examining physician licensing requirements for telehealth visits across state lines, based on the Federation of State Medical Boards' telemedicine policy guidance. 

Promise's analysis confirms that a telehealth physician must be licensed, or otherwise authorized, in the state where the patient is physically located at the time of the visit, not the state where the physician's practice is based, a distinction Promise says patients often overlook, since a telehealth visit doesn't feel geographically specific. 

The announcement comes as the Interstate Medical Licensure Compact issued 3,633 physician licenses in a single month in March 2026, up from just three licenses in its first month of operation in 2017, according to the American Medical Association reporting on Interstate Medical Licensure Compact Commission data.

Promise's consultation model is built around that rule directly: every Promise treatment begins with an online consultation, and a licensed physician determines whether a prescription is appropriate for that specific patient; nothing is issued without provider review, and no program is sold outright. Promise offers doctor-guided programs including sermorelin, semaglutide, and tirzepatide, with each patient's care plan determined individually by the reviewing physician. Promise says this structure keeps licensing compliance and clinical judgment with the physician, not with the platform or the patient alone.

Promise's analysis notes that the infrastructure supporting the licensing rule has grown substantially even as the rule itself has stayed unchanged for years, driven largely by interstate compacts designed to authorize physicians faster across state lines. The Interstate Medical Licensure Compact now spans 44 states, plus D.C. and Guam, according to the American Medical Association reporting on Interstate Medical Licensure Compact Commission data. 

Promise says that growth is precisely why the underlying rule deserves more attention from patients now, rather than less. As licensing pathways multiply and physician networks expand across state lines, verifying that a specific provider is authorized in a patient's own state becomes a more relevant question, not a less relevant one.

Frequently Asked Questions

What does Promise's analysis say about telehealth doctor licensing?

Promise's analysis confirms that a telehealth physician must hold a license, or other state authorization, in the state where the patient is physically located, not where the provider is based, per Federation of State Medical Boards guidance that has governed telemedicine practice for years and remains the operative standard in 2026.

How does Promise ensure patients see a properly licensed physician?

Promise requires every treatment to begin with an online consultation reviewed by a licensed physician, who determines whether a prescription is appropriate before anything is issued, rather than leaving licensure verification to the patient alone.

What programs does Promise offer through its telehealth platform?

Promise offers doctor-guided programs, including sermorelin, semaglutide, and tirzepatide, with prescribing decisions made solely at the discretion of the reviewing physician based on that patient's individual consultation.

About Promise

Promise is a Scottsdale, Arizona-based telehealth platform founded in 2026, offering doctor-guided consultations for peptide therapy, weight management, and hormone care. More information is available at Promise.

Contact